Back
Day Range
$32.32
$33.59
52-Week Range
$18.92
$43.15
Volume
2,280,793
50D / 200D Avg
$32.02
/
$31.99
Prev Close
$32.33
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -10.5 | 0.4 |
| P/B | 5.9 | 2.9 |
| ROE % | -47.3 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$103.00
+216.4%
Low: $99.00
High: $107.00
Forward EPS
-$4.23
Est. Revenue
7.2 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.66
$2.66 – $2.66
|
1.3 B | 5 |
| FY2029 |
-$1.80
-$1.80 – -$1.80
|
450 M | 10 |
| FY2028 |
-$4.16
-$8.20 – -$0.03
|
150 M | 12 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -278.69M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-47.34%
ROIC-46.15%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio9.33
Interest Coverage-7023.96
Valuation
P/E Ratio
-10.46
P/B Ratio5.89
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -359.64M |
| ROE | -47.34% | ROA | -50.25% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -278.69M |
| ROIC | -46.15% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 9.33 |
| Interest Coverage | -7023.96 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -10.46 | P/B Ratio | 5.89 |
| P/S Ratio | N/A | PEG Ratio | -0.05 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 3.76B | Enterprise Value | 3.60B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -359.64M | -109.96M | -85.90M | -68.87M | -54.99M |
| EPS (Diluted) | -3.19 | -1.01 | -0.91 | -0.88 | -0.70 |
| Gross Profit | -431,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -393.34M | -150.92M | -100.83M | -70.36M | -55.68M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 715.73M | 908.32M | 368.49M | 168.53M | 210.66M |
| Total Liabilities | 76.67M | 28.04M | 20.07M | 23.21M | 8.78M |
| Shareholders' Equity | 639.06M | 880.28M | 348.42M | 145.32M | 201.88M |
| Total Debt | 137,000.0 | 1.12M | 1.26M | 1.56M | 29,000.0 |
| Cash & Equivalents | 165.81M | 26.68M | 55.52M | 36.63M | 26.37M |
| Current Assets | 715.60M | 907.22M | 367.23M | 167.04M | 210.53M |
| Current Liabilities | 76.67M | 27.41M | 19.14M | 21.95M | 8.78M |